Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
复制标题
DOI:
10.1016/j.jtho.2017.03.010
复制
发表时间:
2017-06
期刊:
影响因子:
--
通讯作者:
Lai-Goldman M
中科院分区:
文献类型:
--
作者:
Faruki H;Mayhew GM;Serody JS;Hayes DN;Perou CM;Lai-Goldman M
Molecular subtyping of lung adenocarcinoma (AD) and lung squamous cell carcinoma (SCC) reveal biologically diverse tumors that vary in their genomic and clinical attributes. Published immune cell signatures and several lung AD and SCC gene expression data sets, including The Cancer Genome Atlas, were used to examine immune response in relation to AD and SCC expression subtypes. Expression of immune cell populations and other immune related genes, including CD274 molecule gene (CD274) (programmed death ligand 1), was investigated in the tumor microenvironment relative to the expression subtypes of the AD (terminal respiratory unit, proximal proliferative, and proximal inflammatory) and SCC (primitive, classical, secretory, and basal) subtypes. Lung AD and SCC expression subtypes demonstrated significant differences in tumor immune landscape. The proximal proliferative subtype of AD demonstrated low immune cell expression among ADs whereas the secretory subtype showed elevated immune cell expression among SCCs. Tumor expression subtype was a better predictor of immune cell expression than CD274 (programmed death ligand 1) in SCC tumors but was a comparable predictor in AD tumors. Nonsilent mutation burden was not correlated with immune cell expression across subtypes; however, major histocompatibility complex class II gene expression was highly correlated with immune cell expression. Increased immune and major histocompatibility complex II gene expression was associated with improved survival in the terminal respiratory unit and proximal inflammatory subtypes of AD and in the primitive subtype of SCC. Molecular expression subtypes of lung AD and SCC demonstrate key and reproducible differences in immune host response. Evaluation of tumor expression subtypes as potential biomarkers for immunotherapy should be investigated.
登录
查看更多内容
影响因子:
28.2
作者:
Chen PL;Roh W;Reuben A;Cooper ZA;Spencer CN;Prieto PA;Miller JP;Bassett RL;Gopalakrishnan V;Wani K;De Macedo MP;Austin-Breneman JL;Jiang H;Chang Q;Reddy SM;Chen WS;Tetzlaff MT;Broaddus RJ;Davies MA;Gershenwald JE;Haydu L;Lazar AJ;Patel SP;Hwu P;Hwu WJ;Diab A;Glitza IC;Woodman SE;Vence LM;Wistuba II;Amaria RN;Kwong LN;Prieto V;Davis RE;Ma W;Overwijk WW;Sharpe AH;Hu J;Futreal PA;Blando J;Sharma P;Allison JP;Chin L;Wargo JA
通讯作者:
Wargo JA
DOI:
10.1158/1078-0432.ccr-10-0199
发表时间:
2010-10-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Wilkerson MD;Yin X;Hoadley KA;Liu Y;Hayward MC;Cabanski CR;Muldrew K;Miller CR;Randell SH;Socinski MA;Parsons AM;Funkhouser WK;Lee CB;Roberts PJ;Thorne L;Bernard PS;Perou CM;Hayes DN
通讯作者:
Hayes DN
影响因子:
64.5
作者:
Rooney MS;Shukla SA;Wu CJ;Getz G;Hacohen N
通讯作者:
Hacohen N
影响因子:
8
作者:
Schabath MB;Welsh EA;Fulp WJ;Chen L;Teer JK;Thompson ZJ;Engel BE;Xie M;Berglund AE;Creelan BC;Antonia SJ;Gray JE;Eschrich SA;Chen DT;Cress WD;Haura EB;Beg AA
通讯作者:
Beg AA
DOI:
10.1056/nejmoa1504627
发表时间:
2015-07-09
期刊:
The New England journal of medicine
影响因子:
--
作者:
Brahmer J;Reckamp KL;Baas P;Crinò L;Eberhardt WE;Poddubskaya E;Antonia S;Pluzanski A;Vokes EE;Holgado E;Waterhouse D;Ready N;Gainor J;Arén Frontera O;Havel L;Steins M;Garassino MC;Aerts JG;Domine M;Paz-Ares L;Reck M;Baudelet C;Harbison CT;Lestini B;Spigel DR
通讯作者:
Spigel DR